Ken Griffin

Citadel Advisors

Ken Griffin is a prominent investor and the founder of Citadel Advisors, a leading global financial institution known for its quantitative and fundamental investment strategies. Citadel Advisors is recognized for its diverse portfolio, which spans various sectors, including technology and financial services. Recent disclosures reveal a significant focus on major companies like Tesla Inc (TSLA) and NVIDIA Corporation (NVDA), with the latest filing on May 15, 2026, showing a range of position reductions and increases totaling between $23.8B and $6.5B. Notably, the largest disclosed move involved trimming a position in Tesla valued at over $10.7 billion.

Latest Holdings

HoldingReported ValueWeightSharesLast PriceEst. ValueReturn
China Automotive Systems, Inc.CAAS · Q1 2026$42k0%10k$4.39$44k+4.52%
38747R48838747R488 · Q1 2026$42k0%18.7k------
Sphere 3D Corp.ANY · Q1 2026$42k0%28.8k$1.70$49k+17.2%
Invesco Senior Income TrustVVR · Q1 2026$42k0%13k$2.96$38k-8.07%
American Shared Hospital ServicesAMS · Q1 2026$41k0%28.6k$1.41$40k-2.76%
Empire Petroleum CorporationEP · Q1 2026$41k0%13.9k$2.50$35k-15.5%
G88912103G88912103 · Q1 2026$41k0%35.1k------
Bolt Biotherapeutics, Inc.BOLT · Q1 2026$41k0%10.1k$4.42$45k+9.41%
The ONE Group Hospitality, Inc.STKS · Q1 2026$41k0%22.8k$1.90$43k+6.97%
FTC Solar, Inc.FTCI · Q1 2026$40k0%10.7k$3.85$41k+1.85%
46583A30346583A303 · Q1 2026$40k0%157.2k------
69012T30569012T305 · Q1 2026$40k0%194.5k------
ProKidney Corp.PROK · Q1 2026$40k0%22.3k$1.62$36k-9.5%
G4R12K115G4R12K115 · Q1 2026$40k0%16.3k------
BNB Plus Corp.BNBX · Q1 2026$40k0%61.8k$0.163$10k-74.5%
26923N31426923N314 · Q1 2026$39k0%24k------
Mustang Bio, Inc.MBIO · Q1 2026$39k0%53.2k$0.6282$33k-13.7%
T Stamp Inc.IDAI · Q1 2026$39k0%16.2k$2.16$35k-9.62%
G6055H155G6055H155 · Q1 2026$39k0%34.5k------
15672X20115672X201 · Q1 2026$39k0%111.5k------
48208B20348208B203 · Q1 2026$38k0%101.7k------
Mobile Infrastructure CorpBEEP · Q1 2026$38k0%17.1k$1.94$33k-13.4%
G51413154G51413154 · Q1 2026$38k0%45.4k------
SPAR Group, Inc.SGRP · Q1 2026$38k0%60k$0.5857$35k-6.36%
98923T10498923T104 · Q1 2026$38k0%12.8k------
Q0266F107Q0266F107 · Q1 2026$37k0%82.5k------
26923Q21826923Q218 · Q1 2026$37k0%11.8k------
231269309231269309 · Q1 2026$37k0%67k------
G9892K209G9892K209 · Q1 2026$36k0%23.2k------
97651M10997651M109 · Q1 2026$35k0%16.6k------
NaaS Technology Inc.NAAS · Q1 2026$35k0%14.4k$3.25$47k+33.7%
8.3368E+2048.3368E+204 · Q1 2026$34k0%39.4k------
45257L10845257L108 · Q1 2026$33k0%94.2k------
NanoViricides, Inc.NNVC · Q1 2026$33k0%35.9k$1.75$63k+91.9%
77467X10177467X101 · Q1 2026$33k0%14.5k------
G3731B108G3731B108 · Q1 2026$33k0%36.5k------
16307X20216307X202 · Q1 2026$32k0%21.6k------
8.3193E+1068.3193E+106 · Q1 2026$32k0%28.4k------
SelectQuote, Inc.SLQT · Q1 2026$32k0%50.8k$0.7197$37k+14.3%
552939100552939100 · Q1 2026$32k0%10.7k------
Asia Pacific Wire & Cable Corporation LimitedAPWC · Q1 2026$31k0%23.1k$1.46$34k+7.35%
G85727108G85727108 · Q1 2026$31k0%18.5k------
293602504293602504 · Q1 2026$31k0%57.4k------
Myomo, Inc.MYO · Q1 2026$31k0%45.2k$0.9501$43k+40.6%
20/20 Biolabs, Inc. Common StockAIDX · Q1 2026$31k0%16.2k$0.5038$8.2k-73.2%
457637700457637700 · Q1 2026$30k0%47k------
98973P30998973P309 · Q1 2026$30k0%10.5k------
Avalon GloboCare Corp.ALBT · Q1 2026$30k0%56.2k$0.2859$16k-46.2%
Origin Materials, Inc.ORGN · Q1 2026$30k0%13.1k$0.95$12k-58.3%
Century Therapeutics, Inc.IPSC · Q1 2026$30k0%13.1k$2.19$29k-3.1%
Showing 6,501-6,550 of 6,729